Impacto de la intervención farmacéutica realizada a pacientes oncológicos en farmacia comunitaria

  1. Clara Rueda de Lecea
  2. Pilar Gómez-Serranillos Cuadrado
  3. Rafael Lozano Fernández
  4. Irene Iglesias Peinado
  5. Marta Sanchez Gomez-Serranillos
Journal:
Pharmaceutical care España

ISSN: 1139-6202

Year of publication: 2020

Volume: 22

Issue: 2

Pages: 75-94

Type: Article

More publications in: Pharmaceutical care España

Abstract

Introduction: Oncology patients in outpatient treatment with anconstitute a population that can benefit from Pharmaceutical Care. An optimal result of pharmacological therapy is essential to achieve the improvement in the quality of life of these patients. Objective: To carry out a study of pharmaceutical care in patients with cancer in outpatient dispensing treatment in community pharmacy, evaluating the effectiveness of this program. To this end, the evaluation of the adherence to the pharmacological treatment and the control of the symptomatology of the disease are done, recording and documenting the obtained data. Method: This is a quasi-experimental, before-after study with longitudinal, prospective and analytical monitoring. The direct information of each patient was collected through an interview (a total of 95 interviews were conducted) analyzing all aspects related to their medication. Interventions were performed at different levels whenever necessary. Adherence to treatment was assessed by the Morinsky-Green-Levine Test whereas the effectiveness of the intervention on symptomatology was determined using the McNemar statistical test. Results: The total number of patients included in the study were 95. Out of the total, 88.9% of non-adherent patients became adherent after the intervention. The intervention focused on minimizing adverse reactions was significant statistically. Conclusion: In oncological patients, pharmaceutical advice has an impact on therapeutic accomplishment improvement but also in the quality of life of the patient.